Med Life S.A. (BVB:M)

Market Cap	5.46B +38.9%
Revenue (ttm)	3.34B +12.1%
Net Income	-13.97M
EPS	-0.03
Shares Out	530.82M
PE Ratio	n/a
Forward PE	68.53
Dividend	n/a
Ex-Dividend Date	n/a

Volume	329,634
Open	10.04
Previous Close	10.00
Day's Range	9.68 - 10.28
52-Week Range	7.38 - 14.46
Beta	0.39
Analysts	Hold
Price Target	10.89 (+5.93%)
Earnings Date	Aug 28, 2026

About Med Life

Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecul...

• Industry: Health Services
• Founded: 1996
• Employees: 6,962
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: M

Financial Performance

In 2025, Med Life's revenue was 3.17 billion, an increase of 16.86% compared to the previous year's 2.72 billion. Earnings were 11.27 million, a decrease of -55.00%.

Analyst Summary

According to 5 analysts, the average rating for M stock is "Hold." The 12-month stock price target is lei 10.89, which is an increase of 5.93% from the latest price.

Price Target

lei 10.89

(5.93% upside)

Analyst Consensus: Hold

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 23, 2026

Data Sources Report a data error